(trans-4-(4-Amino-3-(difluoromethyl)-1H-pyrazol-1-yl)cyclohexyl)methanol is a stereochemically defined organic building block bearing a substituted pyrazole ring attached at the 4-position of a cyclohexylmethanol skeleton in the trans configuration. The molecule’s molecular formula is C11H17F2N3O and its CAS number is 2434841-21-9. The structural features include a cyclohexane ring (with substituents at positions 1-(methanol) and 4-(pyrazole)), a 4-amino and 3-difluoromethyl substituent on the pyrazole, and the alcohol functionality (methanol) on the cyclohexyl moiety.
In terms of its origin and discovery, the compound appears as a commercial research reagent rather than as a classical target of medicinal chemistry disclosed in academic literature. Its availability from chemical suppliers with stereochemical specification (“(1r,4r)-” or “trans-” cyclohexyl) indicates it is used as a building block for more complex molecules—especially when a difluoromethyl pyrazole fragment is required. The difluoromethyl (–CF2H) substituent on the pyrazole provides a lipophilic and electron-modulating fragment increasingly common in modern medicinal-chemical design, and its attachment to a conformationally defined cyclohexylmethanol scaffold suggests this reagent is introduced when precise spatial geometry is needed in downstream synthesis.
The primary application of this compound is in synthetic chemistry and medicinal-chemistry workflows. It serves as an advanced intermediate or fragment to incorporate a difluoromethylated pyrazole motif into more complex target molecules, such as small-molecule inhibitors or receptor ligands. The stereochemistry (trans-cyclohexyl) ensures fixed orientation of substituents, which can be important for binding-site interactions or structure-activity relationship (SAR) optimisation. The methanol handle on the cyclohexyl unit enables further functionalisation (e.g., activation to a leaving group, oxidation to aldehyde or acid, or derivatisation to ethers/esters) facilitating connection of this fragment into more elaborate scaffolds.
From a practical perspective in the laboratory, this reagent is supplied as a solid (typical purity ≥ 95 %) and should be handled under standard synthetic organic conditions. Given the presence of difluoromethyl and pyrazole functionality, one must consider the possibility of hydrogen-fluorine interactions and potential volatility or moisture sensitivity. Storage in a sealed desiccator and avoidance of strong acids or bases (which may deprotonate the amino group) are recommended. The alcohol functionality also invites potential oxidation or side-reactions if left exposed. Because this building block is used in medicinal-chemistry contexts, the stereochemical integrity (trans-cyclohexyl configuration) and purity (enantiomeric/stereoisomeric excess) are critical for reproducible downstream synthesis and biological screening.
In summary, (trans-4-(4-Amino-3-(difluoromethyl)-1H-pyrazol-1-yl)cyclohexyl)methanol is a modern synthetic reagent designed to deliver a difluoromethyl‐pyrazole motif attached to a stereochemically constrained cyclohexylmethanol scaffold. Its value lies in its use as a fragment in medicinal-chemistry and drug-discovery programmes, where the combination of difluoromethyl substitution, heterocycle (pyrazole) and defined stereochemistry on a cyclohexylmethanol core enables precise molecular design and attachment to further structural units.
|